Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2013, Article ID 532619, 6 pages
http://dx.doi.org/10.1155/2013/532619
Clinical Study

Urinary Eosinophil Protein X in Childhood Asthma: Relation with Changes in Disease Control and Eosinophilic Airway Inflammation

1Department of Pediatric Respiratory Medicine, Juliana Children’s Hospital, HAGA Teaching Hospital, P.O. Box 60605, 2506 LP, The Hague, The Netherlands
2Department of Biostatistics, Erasmus University Medical Centre, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands
3Department of Respiratory Medicine, Academic Medical University of Amsterdam, P.O. Box 22660, 1100 DD, Amsterdam, The Netherlands
4Department of Pediatric Respiratory Medicine, Beatrix Children's Hospital, University Medical Centre Groningen, P.O. Box 30001, 9700 RB, Groningen, The Netherlands
5Department of Pediatric Respiratory Medicine, Sophia Children's Hospital, Erasmus University Medical Centre, P.O. Box 2060, 3000 CB, Rotterdam, The Netherlands

Received 7 November 2012; Accepted 24 December 2012

Academic Editor: Helen C. Steel

Copyright © 2013 Marianne Nuijsink et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Y. Koller, G. Halmerbauer, T. Frischer, and B. Roithner, “Assessment of eosinophil granule proteins in various body fluids: is there a relation to clinical variables in childhood asthma?” Clinical and Experimental Allergy, vol. 29, no. 6, pp. 786–793, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Majamaa, S. Laine, and A. Miettinen, “Eosinophil protein X and eosinophil cationic protein as indicators of intestinal inflammation in infants with atopic eczema and food allergy,” Clinical and Experimental Allergy, vol. 29, no. 11, pp. 1502–1506, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Lugosi, G. Halmerbauer, T. Frischer, and D. Y. Koller, “Urinary eosinophil protein X in relation to disease activity in childhood asthma,” Allergy, vol. 52, no. 5, pp. 584–588, 1997. View at Google Scholar · View at Scopus
  4. E. Tauber, G. Halmerbauer, T. Frischer et al., “Urinary eosinophil protein X in children: the relationship to asthma and atopy and normal values,” Allergy, vol. 55, no. 7, pp. 647–652, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. M. O. Hoekstra, H. Hovenga, J. Gerritsen, and H. F. Kauffman, “Eosinophils and eosinophil-derived proteins in children with moderate asthma,” European Respiratory Journal, vol. 9, no. 11, pp. 2231–2235, 1996. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Severien, A. Artlich, S. Jonas, and G. Becher, “Urinary excretion of leukotriene E4 and eosinophil protein X in children with atopic asthma,” European Respiratory Journal, vol. 16, no. 4, pp. 588–592, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Oosaki, Y. Mizushima, A. Kawasaki, H. Mita, K. Akiyama, and M. Kobayashi, “Correlation among urinary eosinophil protein X, leukotriene E4, and 11-dehydrothromboxane B2 in patients with spontaneous asthmatic attack,” Clinical and Experimental Allergy, vol. 28, no. 9, pp. 1138–1144, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. W. K. Kalaajieh and R. Hoilat, “Asthma attack severity and urinary concentration of eosinophil X protein in children,” Allergologia et Immunopathologia, vol. 30, no. 4, pp. 225–231, 2002. View at Google Scholar · View at Scopus
  9. C. Wojnarowski, B. Roithner, D. Y. Koller et al., “Lack of relationship between eosinophil cationic protein and eosinophil protein X in nasal lavage and urine and the severity of childhood asthma in a 6-month follow-up study,” Clinical and Experimental Allergy, vol. 29, no. 7, pp. 926–932, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Labbe, B. Aublet-Cuvelier, L. Jouaville et al., “Prospective longitudinal study of urinary eosinophil protein X in children with asthma and chronic cough,” Pediatric Pulmonology, vol. 31, no. 5, pp. 354–362, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Kristjánsson, I. L. Strannegård, O. Strannegård, C. Peterson, I. Enander, and G. Wennergren, “Urinary eosinophil protein X in children with atopic asthma: a useful marker of antiinflammatory treatment,” Journal of Allergy and Clinical Immunology, vol. 97, no. 6, pp. 1179–1187, 1996. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Mattes, K. Storm Van's Gravesande, U. Reining et al., “NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma,” European Respiratory Journal, vol. 13, no. 6, pp. 1391–1395, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Nuijsink, W. C. J. Hop, P. J. Sterk, E. J. Duiverman, P. S. Hiemstra, and J. C. De Jongste, “Urinary eosinophil protein X in children with atopic asthma,” Mediators of Inflammation, vol. 2007, Article ID 49240, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Nuijsink, W. C. J. Hop, P. J. Sterk, E. J. Duiverman, and J. C. De Jongste, “Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial,” European Respiratory Journal, vol. 30, no. 3, pp. 457–466, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. A. A. P. H. Verberne, C. Frost, R. J. Roorda et al., “One year treatment with salmeterol compared with beclomethasone in children with asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 156, no. 3 I, pp. 688–695, 1997. View at Google Scholar · View at Scopus
  16. P. H. Quanjer, G. J. Tammeling, J. E. Cotes, O. F. Pedersen, R. Peslin, and J. C. Yernault, “Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal,” The European Respiratory Journal, vol. 16, pp. 5–40, 1993. View at Google Scholar · View at Scopus
  17. D. Birnie, G. W. S. Thoe Schwartzenberg, W. C. J. Hop, E. E. M. Van Essen-Zandvliet, and K. F. Kerrebijn, “Does the outcome of the tidal breathing and dosimeter methods of assessing bronchial responsiveness in children with asthma depend on age?” Thorax, vol. 45, no. 3, pp. 199–202, 1990. View at Google Scholar · View at Scopus
  18. A. Efthimiadis, A. Spanevello, Q. Hamid et al., “Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation,” European Respiratory Journal, vol. 20, no. 37, pp. 19s–23s, 2002. View at Google Scholar · View at Scopus
  19. J. C. C. M. In't Veen, H. W. F. M. De Gouw, H. H. Smits et al., “Repeatability of cellular and soluble markers of inflammation in induced sputum from patients with asthma,” European Respiratory Journal, vol. 9, no. 12, pp. 2441–2447, 1996. View at Google Scholar · View at Scopus
  20. R. Louis, L. C. K. Lau, A. O. Bron, A. C. Roldaan, M. Radermecker, and R. Djukanović, “The relationship between airways inflammation and asthma severity,” American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 1, pp. 9–16, 2000. View at Google Scholar · View at Scopus
  21. L. M. Van Den Toorn, S. E. Overbeek, J. C. De Jongste et al., “Airway inflammation is present during clinical remission of atopic asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 11, pp. 2107–2113, 2001. View at Google Scholar · View at Scopus
  22. M. A. Berry, D. E. Shaw, R. H. Green, C. E. Brightling, A. J. Wardlaw, and I. D. Pavord, “The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma,” Clinical and Experimental Allergy, vol. 35, no. 9, pp. 1175–1179, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Lönnkvist, C. Hellman, J. Lundahl, G. Halldén, and G. Hedlin, “Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: impact of budesonide treatment and withdrawal,” Journal of Allergy and Clinical Immunology, vol. 107, no. 5, pp. 812–817, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Ymar and R. Bjerknes, “Urinary eosinophil protein X in children with atopic dermatitis: relation to atopy and disease activity,” Allergy, vol. 55, no. 10, pp. 964–968, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Pucci, E. Lombardi, E. Novembre et al., “Urinary eosinophil protein X and serum eosinophil cationic protein in infants and young children with atopic dermatitis: correlation with disease activity,” Journal of Allergy and Clinical Immunology, vol. 105, no. 2, pp. 353–357, 2000. View at Google Scholar · View at Scopus